Pfizer files patent suit against 6 pharma firms

The development follows the United States Patent & Trademark Office granting Pfizer a reissue patent covering methods of treating osteoarthritis and other approved conditions with celecoxib.

Written by Press Trust Of India | New Delhi | Published:March 6, 2013 12:45 am

Pfizer Inc today said it has filed suit against six firms,including India’s Lupin,over patent infringement of celecoxib,the active ingredient of its branded drug Celebrex used for treating osteoarthritis.

The development follows the United States Patent & Trademark Office granting Pfizer a reissue patent covering methods of treating osteoarthritis and other approved conditions with celecoxib. “Pfizer filed suit today against Teva Pharmaceuticals USA,Inc,Mylan Pharmaceuticals Inc,Watson Laboratories Inc,Lupin Pharmaceuticals,USA,Inc,Apotex Corp,and Apotex Inc in the United States District Court for the Eastern District of Virginia for infringement of the reissue patent,” Pfizer said in a statement on its website.

For all the latest News Archive News, download Indian Express App

    Live Cricket Scores & Results